Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Guillermo J. Pons-Estel, Manuel F Ugarte-Gil & Graciela S. Alarcón. (2017) Epidemiology of systemic lupus erythematosus. Expert Review of Clinical Immunology 13:8, pages 799-814.
Read now
Read now
S Ekblom-Kullberg, H Kautiainen, P Alha, M Leirisalo-Repo & H Julkunen. (2015) Education, employment, absenteeism, and work disability in women with systemic lupus erythematosus. Scandinavian Journal of Rheumatology 44:2, pages 157-162.
Read now
Read now
S Ekblom-Kullberg, H Kautiainen, P Alha, M Leirisalo-Repo & H Julkunen. (2013) Frequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus. Scandinavian Journal of Rheumatology 42:5, pages 390-393.
Read now
Read now
Donald F Farrell. (2012) Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study. Clinical Ophthalmology 6, pages 377-383.
Read now
Read now
S Ekblom-Kullberg, H Kautiainen, P Alha, T Helve, M Leirisalo-Repo & H Julkunen. (2009) Reproductive health in women with systemic lupus erythematosus compared to population controls. Scandinavian Journal of Rheumatology 38:5, pages 375-380.
Read now
Read now
S Jacobsen, J Petersen, S Ullman, P Junker, A Voss, J. M Rasmussen, U Tarp, L. H Poulsen, G van Overeem Hansen, B Skaarup, T. M Hansen, J Pødenphant, P Halberg. (1999) Mortality and Causes of Death of 513 Danish Patients with Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology 28:2, pages 75-80.
Read now
Read now
M. Gripenberg & T. Helve. (1991) Outcome of Systemic Lupus Erythematosus a Study of 66 Patients over 7 Years with Special Reference to the Predictive Value of Anti-DNA Antibody Determinations. Scandinavian Journal of Rheumatology 20:2, pages 104-109.
Read now
Read now
R. Omdal, S. I. Mellgren & G. Husby. (1988) Clinical Neuropsychiatric and Neuromuscular Manifestations in Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology 17:2, pages 113-117.
Read now
Read now
Anders Wangel. (1986) Serological Tests in the Assessement of Disease Activity in Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology 15:4, pages 353-355.
Read now
Read now
Articles from other publishers (56)
Pia Elfving, Simo Kariniemi, Hannu Kautiainen, Lauri J Virta, Oili Kaipiainen-Seppänen & Kari Puolakka. (2021) Mortality in SLE patients compared with population controls in Finland in years 2000–2015. Rheumatology 60:9, pages 4238-4244.
Crossref
Crossref
Frances Rees, Michael Doherty, Matthew J Grainge, Peter Lanyon & Weiya Zhang. (2017) The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology 56:11, pages 1945-1961.
Crossref
Crossref
Myles J. Lewis & Ali S. Jawad. (2016) The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology, pages kew399.
Crossref
Crossref
C Terao, R Yamada, T Mimori, K Yamamoto & T Sumida. (2014) A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex. Lupus 23:13, pages 1435-1442.
Crossref
Crossref
P Elfving, K Puolakka, H Kautiainen, L J Virta, T Pohjolainen & O Kaipiainen-Seppänen. (2014) Mortality and causes of death among incident cases of systemic lupus erythematosus in Finland 2000–2008. Lupus 23:13, pages 1430-1434.
Crossref
Crossref
Laurent Arnaud, Jean-Paul Fagot, Alexis Mathian, Michel Paita, Anne Fagot-Campagna & Zahir Amoura. (2014) Prevalence and incidence of systemic lupus erythematosus in France: A 2010 nation-wide population-based study. Autoimmunity Reviews 13:11, pages 1082-1089.
Crossref
Crossref
M Scolnik, J Marin, S M Valeiras, M F Marchese, A S Talani, N L Avellaneda, A Etchepare, P Etchepare, M S Plou & E R Soriano. (2014) Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study. Lupus Science & Medicine 1:1, pages e000021.
Crossref
Crossref
Susanne Ekblom-Kullberg, Hannu Kautiainen, Pirkko Alha, Marjatta Leirisalo-Repo, Aaro Miettinen & Heikki Julkunen. (2013) Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus. Rheumatology International 34:3, pages 341-345.
Crossref
Crossref
David J. BrowningDavid J. Browning. 2014. Hydroxychloroquine and Chloroquine Retinopathy. Hydroxychloroquine and Chloroquine Retinopathy
95
106
.
MICHAEL M. WARD. (2013) Estimating Disease Prevalence and Incidence Using Administrative Data: Some Assembly Required. The Journal of Rheumatology 40:8, pages 1241-1243.
Crossref
Crossref
Ali Yazdanyar, Mary Chester Wasko, Lisabeth V. Scalzi, Kevin L. Kraemer & Michael M. Ward. (2013) Short‐Term Perioperative All‐Cause Mortality and Cardiovascular Events in Women With Systemic Lupus Erythematosus. Arthritis Care & Research 65:6, pages 986-991.
Crossref
Crossref
DEBORAH C.C. SOUZA, AUGUSTO H. SANTO & EMILIA I. SATO. (2012) Mortality Profile Related to Systemic Lupus Erythematosus: A Multiple Cause-of-death Analysis. The Journal of Rheumatology 39:3, pages 496-503.
Crossref
Crossref
Chingching FOOCHAROEN, Ratanavadee NANAGARA, Siraphop SUWANNAROJ & Ajanee MAHAKKANUKRAUH. (2011) Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment. International Journal of Rheumatic Diseases 14:4, pages 353-360.
Crossref
Crossref
Cindy H. Flower, Anselm J. M. Hennis & Matthew H. Liang. (2011) Report of an international symposium on narrowing the Gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environments. Current Reviews in Musculoskeletal Medicine 4:3, pages 105-112.
Crossref
Crossref
Catia Duarte, Maura Couto, Luis Ines & Matthew H. Liang. 2011. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
673
696
.
Sean O’Neill & Ricard Cervera. (2010) Systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology 24:6, pages 841-855.
Crossref
Crossref
C-T. Chou. (2010) Alternative therapies: what role do they have in the management of lupus?. Lupus 19:12, pages 1425-1429.
Crossref
Crossref
J. NossentN. Cikes, E. Kiss, A. Marchesoni, V. Nassonova, M. Mosca, M. Olesinska, G. Pokorny, B. Rozman, M. Schneider, P.G. Vlachoyiannopoulos & A. Swaak. (2016) Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual. Lupus 16:5, pages 309-317.
Crossref
Crossref
J DadonieneD Adomaviciute, R Rugiene, A Luksiene & A Venalis. (2016) The Prevalence of Systemic Lupus Erythematosus in Lithuania: The Lowest Rate in Northern Europe. Lupus 15:8, pages 544-546.
Crossref
Crossref
N DanchenkoJ A Satia & M S Anthony. (2016) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15:5, pages 308-318.
Crossref
Crossref
Sònia Jiménez, M. Angels García-Criado, Dolors Tàssies, Joan Carles Reverter, Ricard Cervera, M. Rosa Gilabert, Daniel Zambón, Emilio Ros, Concepció Bru & Josep Font. (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 44:6, pages 756-761.
Crossref
Crossref
R. Fischer-Betz, S. Beer & M. Schneider. (2005) Beschleunigte Arteriosklerose bei rheumatischen Systemerkrankungen am Beispiel des systemischen Lupus erythematodes—was ist die Konsequenz?Considering systemic lupus erythematosus as example for accelerated atherosclerosis in rheumatic diseases—what is the consequence?. Zeitschrift für Rheumatologie 64:4, pages 229-238.
Crossref
Crossref
Sònia Jiménez, Ricard Cervera, Miguel Ingelmo & Josep Font. 2005. Cutaneous Lupus Erythematosus. Cutaneous Lupus Erythematosus
33
44
.
Sari Koskenmies, Elisabeth Widén, Päivi Onkamo, Petteri Sevón, Heikki Julkunen & Juha Kere. (2004) Haplotype associations define target regions for susceptibility loci in systemic lupus erythematosus. European Journal of Human Genetics 12:6, pages 489-494.
Crossref
Crossref
Michelle Petri. 2004. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
913
942
.
Dafna D. Gladman. 2004. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
697
715
.
Ricard Cervera, Sònia Jiménez, Josep Font & Miguel Ingelmo. (2003) The epidemiology of systemic lupus erythematosus: a review of the current data with special emphasis on the lessons from the ‘Euro-lupus Cohort’. APLAR Journal of Rheumatology 6:2, pages 150-157.
Crossref
Crossref
Olivier Meyer. (2002) Lupus systémique chez les non-Caucasiens. Revue du Rhumatisme 69:8, pages 801-808.
Crossref
Crossref
Sònia Jiménez, Josep Font & Miguel Ingelmo. (2002) Lupus eritematoso sistémico y enfermedad cardiovascular. Medicina Clínica 119:18, pages 699-706.
Crossref
Crossref
Olivier Meyer. (2001) Atherosclerosis and connective tissue diseases. Joint Bone Spine 68:6, pages 564-575.
Crossref
Crossref
Olivier Meyer. (2001) Athérosclérose et connectivites. Revue du Rhumatisme 68:10-11, pages 931-943.
Crossref
Crossref
Jane E. Salmon & Mary J. Roman. (2001) Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management. Current Opinion in Rheumatology 13:5, pages 341-344.
Crossref
Crossref
Francesco Violi, Fausta Micheletta & Luigi Iuliano. 2001. Atherosclerosis and Autoimmunity. Atherosclerosis and Autoimmunity
273
278
.
Sònia Jiménez, Manuel Ramos-Casals, Ricard Cervera, Josep Font & Miguel Ingelmo. 2001. Atherosclerosis and Autoimmunity. Atherosclerosis and Autoimmunity
255
265
.
Michael M. Ward. (2000) Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis. American Journal of Kidney Diseases 36:3, pages 516-525.
Crossref
Crossref
M Petri. (2016) Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 9:3, pages 170-175.
Crossref
Crossref
Michael M. Ward. (1999) Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis & Rheumatism 42:2, pages 338-346.
Crossref
Crossref
Denise L. Jacobson, Stephen J. Gange, Noel R. Rose & Neil M.H. Graham. (1997) Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States. Clinical Immunology and Immunopathology 84:3, pages 223-243.
Crossref
Crossref
IS Gourley, CC Patterson & AL Bell. (2016) The Prevalence of Systemic Lupus Erythematosus in Northern Ireland. Lupus 6:4, pages 399-403.
Crossref
Crossref
Leigh F. Callahan & Theodore Pincus. (2005) Mortality in the rheumatic diseases. Arthritis & Rheumatism 8:4, pages 229-241.
Crossref
Crossref
Michael M. Ward, Elise Pyun & Stephanie Studenski. (2005) Causes of death in systemic lupus erythematosus, long‐term followup of an inception cohort. Arthritis & Rheumatism 38:10, pages 1492-1499.
Crossref
Crossref
Chairat Shayakul, Leena Ong-aj-yooth, Phisit Chirawong, Sumalee Nimmannit, Paisal Parichatikanond, Tawee Laohapand, Somkiat Vasuvattakul, Kriengsak Vareesangthip, Supat Vanichakarn, Prida Malasit & Sanga Nilwarangkur. (1995) Lupus Nephritis in Thailand: Clinicopathologic findings and outcome in 569 patients. American Journal of Kidney Diseases 26:2, pages 300-307.
Crossref
Crossref
S. R. Alballa. (1995) Systemic lupus erythematosus in Saudi patients. Clinical Rheumatology 14:3, pages 342-346.
Crossref
Crossref
Michael Dennis. (2004) Neuropsychiatric lupus erythematosus and the elderly. International Journal of Geriatric Psychiatry 9:2, pages 97-106.
Crossref
Crossref
E. Kinnunen, P. Järvinen, L. Ketonen & R. Sepponen. (1993) Co-twin control study on cerebral manifestations of systemic lupus erythematosus. Acta Neurologica Scandinavica 88:6, pages 422-426.
Crossref
Crossref
N. M. Anstey, I. Bastian, H. Dunckley & B. J. Currie. (2008) Systemic lupus erythematosus in Australian Aborigines: high prevalence, morbidity and mortality. Australian and New Zealand Journal of Medicine 23:6, pages 646-651.
Crossref
Crossref
E. Kinnunen, K. Müller, P. Keto, L. Ketonen, T. Helve & R. Sepponen. (2009) Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurologica Scandinavica 87:5, pages 356-360.
Crossref
Crossref
Thomas G. Benedek. 2008. The Cambridge World History of Human Disease. The Cambridge World History of Human Disease
848
852
.
Jerry C. JacobsJerry C. Jacobs. 1993. Pediatric Rheumatology for the Practitioner. Pediatric Rheumatology for the Practitioner
409
526
.
M. G. Cohen & E. K. Li. (2008) Mortality in systemic lupus erythematosus: active disease is the most important factor. Australian and New Zealand Journal of Medicine 22:1, pages 5-8.
Crossref
Crossref
P. JÄRVINE, J. KAPRIO, R. MÄKITALO, M. Koskenvuo & K. Aho. (1992) Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features. Journal of Internal Medicine 231:1, pages 67-72.
Crossref
Crossref
R. Roubenoff & M. C. Hochberg. 1991. Prognosis in the Rheumatic Diseases. Prognosis in the Rheumatic Diseases
193
212
.
Marc C. Hochberg. (1990) Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America 16:3, pages 617-639.
Crossref
Crossref
P. W. Thompson. 1989. Infections and Athritis. Infections and Athritis
85
92
.
M C Hochberg. (1987) Prevalence of systemic lupus erythematosus in England and Wales, 1981-2.. Annals of the Rheumatic Diseases 46:9, pages 664-666.
Crossref
Crossref
. (1987) Sudden death in a 22-year-old woman with lupus erythematosus. The American Journal of Medicine 82:1, pages 65-72.
Crossref
Crossref